Neutralization Activity of Standard and Hyperimmune Intravenous Immunoglobulins Against Recently Circulating SARS-CoV-2 Variants
Sign Up to like & getrecommendations! Published in 2025 at "Vaccines"
DOI: 10.3390/vaccines13070760
Abstract: Our study demonstrates that IVIG lots manufactured in 2023–2024 contain neutralizing antibodies against circulating Omicron variants, including KP.3 and XEC. These variants are resistant to all convalescent plasma and IVIG preparations produced prior to 2023.… read more here.
Keywords: sars cov; cov variants; activity standard; standard hyperimmune ... See more keywords